• Bionano files $30M IPO to fund its long base pair DNA sequencers fiercebiotech
    August 07, 2018
    DNA analyzer manufacturer Bionano Genomics filed for a $30 million IPO, with plans to expand its commercial operations and potentially establish a direct commercialization foothold in China. It plans to use the Nasdaq symbol BNGO.
PharmaSources Customer Service